Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

46 results about "Fovea centralis" patented technology

The fovea centralis is a small, central pit composed of closely packed cones in the eye. It is located in the center of the macula lutea of the retina. The fovea is responsible for sharp central vision (also called foveal vision), which is necessary in humans for activities for which visual detail is of primary importance, such as reading and driving. The fovea is surrounded by the parafovea belt and the perifovea outer region.

Visual target tracking method of bionic retina

The invention discloses a visual target tracking method of a bionic retina, and belongs to the field of photoelectric target tracking. According to the invention, the variable resolution characteristic of bionic retina imaging is mainly utilized, and the field of view is mapped to the logarithm polar coordinates for target tracking. Firstly, logarithm polar coordinate mapping imaging of a bionic retina is utilized, a target tracking algorithm is improved through the staring effect of a fovea centralis, the information compression effect of an edge and real-time parameters, redundant data are compressed, detail information of an interested target is enhanced, and the information acquisition efficiency in a view field range is improved. And meanwhile, target information in a scene is accurately grasped by utilizing singular points and imaging threshold judgment, and the reliability of target screening is improved. And finally, real-time target tracking is realized by comparing an eccentricity judgment algorithm with higher speed with the motion control module. Compared with a traditional method, under the condition of a large field of view and high resolution, real-time target tracking is achieved on the basis of a bionic retina vision mechanism, efficiency is higher, and precision is higher.
Owner:BEIJING INSTITUTE OF TECHNOLOGYGY

SD-OCT image macular fovea centralis center positioning method

The invention discloses an SD-OCT image macular fovea centralis center positioning method. The method comprises the following steps: segmenting an inner boundary film layer and a Bloom film layer of an SD-OCT image; extracting each column of pixels between the inner boundary film layer and the Bloom film layer as features; training a random forest classifier to segment a fovea centralis non-vascular region, and calculating the geometric center position of the fovea centralis non-vascular region as the rough center position P1 of the macular fovea centralis; a retina thickness image is generated within a certain range with P1 as the center; judging whether the retina in the area is sunken or not, and if yes, taking the position at the minimum thickness value as a new foveal fovea central position P2; if not, the P2 is still the position of the P1; and searching a central concave high-reflection region around the position P2, if the high-reflection region exists, taking the central position of the high-reflection region as a final central concave central position P3, and otherwise, taking the P3 as the position P2. Compared with the conventional method for positioning only accordingto the thickness change of the retina, the robustness and the precision of the method are greatly improved.
Owner:NANJING UNIV OF SCI & TECH +2

Method for realizing flexible central fovea imaging based on rotary biprism imaging system

ActiveCN113759543AReduce in quantityGuaranteed Foveal Imaging PerformanceImage enhancementPrismsImage resolutionEngineering
The invention relates to a method for realizing flexible central fovea imaging based on a rotary biprism imaging system. The method comprises the steps of S1, constructing a rotary biprism imaging system; S2, constructing a fitness function, and defining a definition and calculation method of a fitness value; S3, determining a region of interest and the number of sub-images, and solving a prism rotation angle by using a particle swarm optimization algorithm; S4, sequentially adjusting the rotation angles of the prisms according to the result of the particle swarm optimization algorithm, and collecting images; S5, carrying out distortion correction on the collected images; S6, splicing the distorted and corrected images to obtain a large field of view; and S7, performing super-resolution reconstruction on the region of interest to further improve the resolution of the central fovea region. According to the invention, central fovea imaging with flexible adjustment of the region of interest can be realized, and acquisition of an overall large field of view is considered. Besides, central fovea imaging can be realized only by using the single rotary biprism imaging system, so that the complexity of equipment is greatly reduced, and the method has excellent practical value.
Owner:FUZHOU UNIV

Methods of expressing a polynucleotide of interest in the cone photoreceptors of a subject comprising the subretinal delivery of a therapeutically effective amount of a recombinant aav9-derived vector

Intraocular injection of adeno-associated viral (AAV) vectors has been an evident route for delivering gene drugs into the retina. Currently, the vectors need to be injected into the subretinal spacein order to provide gene delivery to cones. In this approach, gene delivery is limited to cells that contact the local "bleb" of injected fluid. Furthermore, retinal detachment that occurs during subretinal injections is a concern in eyes with retinal degeneration. Here, the inventors establish several new vector-promoter combinations to overcome the limitations associated with AAV-mediated cone transduction in the fovea with supporting studies in mouse models, human induced pluripotent stem cell-derived organoids, post-mortem human retinal explants and living macaques. They show that an AAV9variant provides efficient foveal cone transduction when injected into the subretinal space several millimeters away from the fovea, without detaching this delicate region. The delivery modality relies on a cone-specific promoter and result in high-level transgene expression compatible with optogenetic vision restoration. Accordingly, the present invention relates to method of expressing a polynucleotide of interest in the cone photoreceptors of a subject comprising subretinal delivery of a therapeutically effective amount of a recombinant AAV9-derived vector comprising a VP1 capsid protein asset forth in SEQ ID NO: 11 and the polynucleotide of interest under the control of the pR1.7 promoter as set forth in SEQ ID NO: 12.
Owner:ASSISTANCE PUBLIQUE HOPITAUX DE PARIS +1

Bionic visual image target recognition method fusing dot-line memory information

ActiveCN110598534APrecise and detailed visual contentImprove recognition rateCharacter and pattern recognitionSensory cellViewpoints
The invention discloses a bionic visual image target recognition method fusing dot-line memory information, and the method comprises the steps of constructing a grid cell set based on visual drive, constructing a distance cell model, and calculating a displacement vector between the positions coded by a grid cell group vector; calculating the response of all sensory neurons to each central concavepixel k through a Gaussian kernel, wherein the response is used for target recognition; calculating the fovea centralis of the current target image by using Gaussian nuclear sensory cells, taking thefeature tag unit with the strongest response as the next jump point, and accumulating the corresponding stimulated identity cells; selecting a next-hop viewpoint, and updating a foveal displacement vector through a distance cell model; and circularly repeating the calculation of the current position during the target identification process, selecting the next-hop viewpoint, and carrying out the vector calculation until the accumulation of a certain stimulated identity cell reaches a threshold value 0.9, and considering the stimulated identity as the finally identified target. The method provided by the invention has a relatively higher recognition rate for the position change, zooming and shielded images.
Owner:CENT SOUTH UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products